| Term 
 
        | Polyenes Drugs? MOA? Mechanism of resistance? |  | Definition 
 
        | Amphotericin B Nystatin   Interact with ergosterol in fungal membranes to form artificial 'pores' which disrupt membrane permeability   Strains with low amount of ergosterol or altered ergosterol in their membranes  |  | 
        |  | 
        
        | Term 
 
        | Amophotericin B MOA? Use? ADR? |  | Definition 
 
        | Interacts with ergosterol in the fungal membranes to form artificial 'pores' which disrupt the membrane permeability   WIDE fungal spectrum DOC for Aspergillus, Candida, Cryptococcus, Histoplasma, Sporothrix   Infusion related : Fever, chills, hypotension Dose dependent: Nephrotoxicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Interacts with ergosterol in fungal membranes to form artificial 'pores' which disrupt the membrane permeability   Topically for localised infections i.e candidiasis & Orally to treat GI fungal infections in immune compromised patients |  | 
        |  | 
        
        | Term 
 
        | Flucytosine MOA Resistance? Use? ADR? |  | Definition 
 
        | Activated by fungal cytosine deaminase to 5-fluorouracil (5FU) - this inhibits thymidylate synthase - which decreases the amount of thymine   Resistance is acquired via decreased activity of the deaminase   Used in the MANAGEMENT of cryptococcal infections   Toxic to bone marrow & alopecia |  | 
        |  | 
        
        | Term 
 
        | What is use in the prophylaxis of Cryptococcal infections   What is used in the management of cryptociccal infections |  | Definition 
 
        | - Fluconazole   
 - Flucytosine |  | 
        |  | 
        
        | Term 
 
        | Allylamines Drug? MOA Use? |  | Definition 
 
        | Terbinafine Inhibits squalene epoxidase - decreases ergosterol from fungal cell wall   DOC: Onychomycosis (due to increase in concentration in nail beds) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Ketoconazole Fluconazole   Interferes with the synthesis of ergosterol by inhibiting lanosterol 14 aloha demethylase, which normally converts lanosterol to ergosterol |  | 
        |  | 
        
        | Term 
 
        | Ketoconazole MOA Use? ADR |  | Definition 
 
        | interferes with the synthesis of ergosterol by inhibiting lanosterol 14 alpha demethylase which converts lanosterol to ergosterol   Oral use   Drug interactions*** (it will increase the blood levels of warfarin, sulfonylureas, phenytoin etc)  Liver toxicity Inhibits testosterone synthesis |  | 
        |  | 
        
        | Term 
 
        | Fluconazole MOA Use? ADR? |  | Definition 
 
        | Interferes with the synthesis of ergosterol by inhibiting lanosterol 14 alpha demethylase, which converts lanosterol to ergosterol   DOC: Prophylaxis of cryptococcal meningitis Vaginal candidiasis (single dose)   **less drug interactions in comparison to Ketoconazole |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Griseofulvin MOA Use ADR? |  | Definition 
 
        | Binds to microtubules/disrupts mitosis   Deposits in newly formed keratin - skin, hair & nail infections 
 Photosensativitiy Rash Peripheral neuritis Drug inhibitor  Phenobarbitone decreases the oral absorption thus leading to failure of the drug |  | 
        |  |